Additionally, the increase of splenic CD8+ PD1+ cells on Day 8 after PhIR was consistent with the study reporting that peripheral CD8+ PD1+ T cells significantly increased after radiotherapy in responsive prostate cancer patients, with an explanation that PD1 expression was expected to be a potential marker for tumor response.30 The gene discussed is CD8A; the disease is prostate carcinoma.